ClinicalTrials.govpublic full text
Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan.
esophageal carcinoma, cisplatin, irinotecan, radiation therapy, 02-045, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 859613
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.